Comparing efficacy of BCG/lactoferrin primary vaccination versus booster regimen

Tuberculosis

Volumn 91, Issue SUPPL. 1, 2011, Pages

  Hwang, Shen An ^a   Welsh, Kerry J ^a   Boyd, Sydney ^a   Kruzel, Marian L ^a   Actor, Jeffrey K ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Adjuvant; BCG; Lactoferrin; Tuberculosis; Vaccine

Indexed keywords

BCG VACCINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; LACTOFERRIN; MYCOBACTERIUM ANTIGEN;

ADJUVANT THERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL LOAD; BCG VACCINATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; FEMALE; IMMUNE RESPONSE; LUNG GRANULOMA; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; SINGLE DRUG DOSE; SPLEEN CELL; TREATMENT DURATION; TREATMENT OUTCOME; TUBERCULOSIS;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BACTERIAL LOAD; BCG VACCINE; COLONY COUNT, MICROBIAL; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; IMMUNIZATION, SECONDARY; LACTOFERRIN; LIVER; LUNG; MICE; MICE, INBRED C57BL; MYCOBACTERIUM TUBERCULOSIS; SPLEEN; TUBERCULOSIS, PULMONARY; VACCINATION;

EID: 84655163938     PISSN: 14729792     EISSN: 1873281X     Source Type: Journal    
DOI: 10.1016/j.tube.2011.10.017     Document Type: Article

References (44)

1. J.K. Actor, S.A. Hwang, and M.L. Kruzel Lactoferrin as a natural immune modulator Curr Pharm Des 15 2009 1956 1973
2. E. Damiens, J. Mazurier, I. el Yazidi, M. Masson, I. Duthille, G. Spik, and Y. Boilly-Marer Effects of human lactoferrin on NK cell cytotoxicity against haematopoietic and epithelial tumour cells Biochim Biophys Acta 1402 1998 277 287 (Pubitemid 28206922)
3. S.A. Hwang, K.M. Wilk, Y.A. Bangale, M.L. Kruzel, and J.K. Actor Lactoferrin modulation of IL-12 and IL-10 response from activated murine leukocytes Med Microbiol Immunol 196 2007 171 180 (Pubitemid 47300255)
4. C.S. Curran, K.P. Demick, and J.M. Mansfield Lactoferrin activates macrophages via TLR4-dependent and -independent signaling pathways Cell Immunol 242 2006 23 30 (Pubitemid 44894393)
5. I. Dhennin-Duthille, M. Masson, E. Damiens, C. Fillebeen, G. Spik, and J. Mazurier Lactoferrin upregulates the expression of CD4 antigen through the stimulation of the mitogen-activated protein kinase in the human lymphoblastic T Jurkat cell line J Cell Biochem 79 2000 583 593
6. M. Zimecki, J. Mazurier, G. Spik, and J.A. Kapp Human lactoferrin induces phenotypic and functional changes in murine splenic B cells Immunology 86 1995 122 127
7. M. Spadaro, C. Caorsi, P. Ceruti, A. Varadhachary, G. Forni, F. Pericle, and M. Giovarelli Lactoferrin, a major defense protein of innate immunity, is a novel maturation factor for human dendritic cells Faseb J 22 2008 2747 2757
8. R. Fischer, H. Debbabi, M. Dubarry, P. Boyaka, and D. Tome Regulation of physiological and pathological Th1 and Th2 responses by lactoferrin Biochem Cell Biol 84 2006 303 311 (Pubitemid 44341305)
9. I. Frydecka, M. Zimecki, D. Bocko, A. Kosmaczewska, R. Teodorowska, L. Ciszak, M. Kruzel, J. Wlodarska-Polinsk, K. Kuliczkowski, and J. Kornafel Lactoferrin-induced up-regulation of zeta (zeta) chain expression in peripheral blood T lymphocytes from cervical cancer patients Anticancer Res 22 2002 1897 1901 (Pubitemid 34839217)
10. S.A. Hwang, M.L. Kruzel, and J.K. Actor Influence of bovine lactoferrin on expression of presentation molecules on BCG-infected bone marrow derived macrophages Biochimie 91 2009 76 85
11. S.A. Hwang, and J.K. Actor Lactoferrin modulation of BCG-infected dendritic cell functions Int Immunol 21 2009 1185 1197
12. P. Andersen, and T.M. Doherty The success and failure of BCG - implications for a novel tuberculosis vaccine Nat Rev Microbiol 3 2005 656 662 (Pubitemid 41052152)
13. M.J. Brennan The tuberculosis vaccine challenge Tuberculosis (Edinb) 85 2005 7 12 (Pubitemid 40431309)
14. WHO Global tuberculosis control: epidemiology, strategy, financing 2009 WHO
15. C.A. Thaiss, and S.H. Kaufmann Toward novel vaccines against tuberculosis: current hopes and obstacles Yale J Biol Med 83 4 2010 Dec 209 215
16. T. Hawkridge, and H. Mahomed Prospects for a new, safer and more effective TB vaccine Paediatr Respir Rev 12 1 2011 Mar 46 51
17. M.M. Ho, J. Southern, H.N. Kang, and I. Knezevic WHO Informal Consultation on standardization and evaluation of BCG vaccines Geneva, Switzerland 22-23 September 2009 Vaccine 28 2009 6945 6950
18. S.A. Hwang, R. Arora, M.L. Kruzel, and J.K. Actor Lactoferrin enhances efficacy of the BCG vaccine: comparison between two inbred mice strains (C57BL/6 and BALB/c) Tuberculosis (Edinb) 89 Suppl. 1 2009 S49 S54
19. S.A. Hwang, K. Wilk, M.L. Kruzel, and J.K. Actor A novel recombinant human lactoferrin augments the BCG vaccine and protects alveolar integrity upon infection with Mycobacterium tuberculosis in mice Vaccine 27 2009 3026 3034
20. S.A. Hwang, K.M. Wilk, M. Budnicka, M. Olsen, Y.A. Bangale, R.L. Hunter, M.L. Kruzel, and J.K. Actor Lactoferrin enhanced efficacy of the BCG vaccine to generate host protective responses against challenge with virulent Mycobacterium tuberculosis Vaccine 25 2007 6730 6743 (Pubitemid 47332728)
21. S.A. Hwang, K.J. Welsh, M. Kruzel, and J.K. Actor A mini-review: lactoferrin augmentation of the BCG vaccine leads to increased pulmonary integrity Tuberculosis Res Treat 2011
22. J.C. Hope, and B. Villarreal-Ramos Bovine TB and the development of new vaccines Comp Immunol Microbiol Infect Dis 31 2008 77 100 (Pubitemid 351315112)
23. C. Locht, C. Rouanet, J.M. Hougardy, and F. Mascart How a different look at latency can help to develop novel diagnostics and vaccines against tuberculosis Expert Opin Biol Ther 7 2007 1665 1677 (Pubitemid 350157493)
24. D.J. Padilla-Carlin, D.N. McMurray, and A.J. Hickey The guinea pig as a model of infectious diseases Comp Med 58 2008 324 340
25. C.Y. Chen, D. Huang, R.C. Wang, L. Shen, G. Zeng, S. Yao, Y. Shen, L. Halliday, J. Fortman, M. McAllister, J. Estep, R. Hunt, D. Vasconcelos, G. Du, S.A. Porcelli, M.H. Larsen, W.R. Jacobs Jr., B.F. Haynes, N.L. Letvin, and Z.W. Chen A critical role for CD8 T cells in a nonhuman primate model of tuberculosis PLoS Pathog 5 2009 e1000392
26. H. Bruns, C. Meinken, P. Schauenberg, G. Harter, P. Kern, R.L. Modlin, C. Antoni, and S. Stenger Anti-TNF immunotherapy reduces CD8+ T cell-mediated antimicrobial activity against Mycobacterium tuberculosis in humans J Clin Invest 119 2009 1167 1177
27. L.A. van Pinxteren, J.P. Cassidy, B.H. Smedegaard, E.M. Agger, and P. Andersen Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells Eur J Immunol 30 2000 3689 3698 (Pubitemid 32005243)
28. J. Wang, M. Santosuosso, P. Ngai, A. Zganiacz, and Z. Xing Activation of CD8 T cells by mycobacterial vaccination protects against pulmonary tuberculosis in the absence of CD4 T cells J Immunol 173 2004 4590 4597 (Pubitemid 39280692)
29. T.D. Bold, and J.D. Ernst Who benefits from granulomas, mycobacteria or host? Cell 136 2009 17 19
30. M. Kursar, M. Koch, H.W. Mittrucker, G. Nouailles, K. Bonhagen, T. Kamradt, and S.H. Kaufmann Cutting edge: regulatory T cells prevent efficient clearance of Mycobacterium tuberculosis J Immunol 178 2007 2661 2665 (Pubitemid 46333142)
31. K.M. Quinn, F.J. Rich, L.M. Goldsack, G.W. de Lisle, B.M. Buddle, B. Delahunt, and J.R. Kirman Accelerating the secondary immune response by inactivating CD4(+)CD25(+) T regulatory cells prior to BCG vaccination does not enhance protection against tuberculosis Eur J Immunol 38 2008 695 705
32. C. Paige, and W.R. Bishai Penitentiary or penthouse condo: the tuberculous granuloma from the microbe's point of view Cell Microbiol 12 3 2010 Mar 301 309
33. R.L. Hunter, L. Armitige, C. Jagannath, and J.K. Actor TB research at UT-Houston-a review of cord factor: new approaches to drugs, vaccines and the pathogenesis of tuberculosis Tuberculosis (Edinb) 89 Suppl. 1 2009 S18 S25
34. K.J. Welsh, S.A. Risin, J.K. Actor, and R.L. Hunter Immunopathology of postprimary tuberculosis: increased T-regulatory cells and DEC-205-positive foamy macrophages in cavitary lesions Clin Dev Immunol 2011 307631
35. P.E. Fine Herd immunity: history, theory, practice Epidemiol Rev 15 1993 265 302 (Pubitemid 24072630)
36. E. Torrado, and A.M. Cooper IL-17 and Th17 cells in tuberculosis Cytokine Growth Factor Rev 21 6 2010 Dec 455 462
37. W. Ouyang, J.K. Kolls, and Y. Zheng The biological functions of T helper 17 cell effector cytokines in inflammation Immunity 28 2008 454 467 (Pubitemid 351471762)
38. P. Seiler, P. Aichele, S. Bandermann, A.E. Hauser, B. Lu, N.P. Gerard, C. Gerard, S. Ehlers, H.J. Mollenkopf, and S.H. Kaufmann Early granuloma formation after aerosol Mycobacterium tuberculosis infection is regulated by neutrophils via CXCR3-signaling chemokines Eur J Immunol 33 2003 2676 2686 (Pubitemid 37337133)
39. M. Umemura, A. Yahagi, S. Hamada, M.D. Begum, H. Watanabe, K. Kawakami, T. Suda, K. Sudo, S. Nakae, Y. Iwakura, and G. Matsuzaki IL-17-mediated regulation of innate and acquired immune response against pulmonary Mycobacterium bovis bacille Calmette-Guerin infection J Immunol 178 2007 3786 3796 (Pubitemid 46417647)
40. E.B. Eruslanov, I.V. Lyadova, T.K. Kondratieva, K.B. Majorov, I.V. Scheglov, M.O. Orlova, and A.S. Apt Neutrophil responses to Mycobacterium tuberculosis infection in genetically susceptible and resistant mice Infect Immun 73 2005 1744 1753 (Pubitemid 40470763)
41. C. Keller, R. Hoffmann, R. Lang, S. Brandau, C. Hermann, and S. Ehlers Genetically determined susceptibility to tuberculosis in mice causally involves accelerated and enhanced recruitment of granulocytes Infect Immun 74 2006 4295 4309 (Pubitemid 43993363)
42. A. Cruz, A.G. Fraga, J.J. Fountain, J. Rangel-Moreno, E. Torrado, M. Saraiva, D.R. Pereira, T.D. Randall, J. Pedrosa, A.M. Cooper, and A.G. Castro Pathological role of interleukin 17 in mice subjected to repeated BCG vaccination after infection with Mycobacterium tuberculosis J Exp Med 207 8 2010 Aug 2 1609 1616
43. A.A. Awomoyi, A. Marchant, J.M. Howson, K.P. McAdam, J.M. Blackwell, and M.J. Newport Interleukin-10, polymorphism in SLC11A1 (formerly NRAMP1), and susceptibility to tuberculosis J Infect Dis 186 2002 1808 1814 (Pubitemid 35463514)
44. P.S. Redford, A. Boonstra, S. Read, J. Pitt, C. Graham, E. Stavropoulos, G.J. Bancroft, and A. O'Garra Enhanced protection to Mycobacterium tuberculosis infection in IL-10-deficient mice is accompanied by early and enhanced Th1 responses in the lung Eur J Immunol 40 8 2010 Aug 2200 2210